Ruemu Birhiray, MD of Hematology Oncology of Indiana, leads two other experts in an exploration of the latest advancements in follicular lymphoma treatment, with a focus on bispecific antibodies presented at the 66th American Society of Hematology Annual Meeting and Exposition. The experts analyze data on epcoritamab combinations, response rates, and safety, addressing community adoption challenges and strategies to enhance accessibility and tolerability.
- Category
- Oncology

Be the first to comment